Program Leaders

Margaret A. Shupnik, PhD
Professor, Department of Medicine, Division of Endocrinology and Metabolism
Leader, Women’s Oncology Program
Estrogen receptor (ER) signaling networks in breast cancer; pathways to therapeutic resistance in ER-positive breast cancers.

Paula M. Fracasso, MD, PhD
Professor, Department of Medicine, Division of Hematology/Oncology
Deputy Director and Acting Associate Director for Clinical Research, Cancer Center
Leader, Women's Oncology Program
Clinical trials of targeted agents in women’s malignancies.

Full Program Members

Amy H. Bouton, PhD
Professor, Department of Microbiology
Role of c-Src-Cas-BCAR3 signaling in breast cancer and resistance to endocrine and chemotherapies; role of focal adhesion signaling in macrophages in breast tumor growth and metastasis.

David R. Brenin, MD
Associate Professor, Department of Surgery; Co-leader, Breast Cancer Interdisciplinary Clinical Care Team
Immunotherapy in breast cancer; collaborative analysis of T-cell trafficking in women with early stage breast cancer following peptide vaccination.

Leigh Cantrell, MD
Assistant Professor, Gynecologic Oncology, Obstetrics and Gynecology
Carcinosarcoma and minimally  invasive surgery for patients with cancer

Wendy Cohn, PhD
Associate Professor, Department of Public Health Sciences
Family history-based genomic risk assessment and clinical decision support tool; genome enabled medical record.

Mark R. Conaway, PhD
Professor of Public Health Sciences
Unique statistical models for phase I clinical trials and the evaluation of new cancer therapies.

Janet V. Cross, PhD
Assistant Professor, Department of Pathology
Role of inflammatory cytokines in interactions between both primary and metastatic breast cancer and the immune system.

Patrick M. Dillon, MD
Assistant Professor, Department of Medicine, Division of Hematology/Oncology
Clinical investigations of immunotherapy and molecular targets in breast cancer.

Linda R. Duska, MD
Associate Professor, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology
Clinical trials in women with gynecologic cancers with emphasis on neoadjuvant therapy in cervical cancer.

Kevin A. Janes, PhD
Assistant Professor, Department of Biomedical Engineering; School of Engineering and Applied Science
Systems and computational approaches of HER family signaling networks causing abnormal growth of breast epithelial and breast cancer cells.

Amir A. Jazaeri, MD
Assistant Professor, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology
Molecular characterization and development of biomarkers to identify the earliest stages of ovarian carcinoma; examination of the role of DNA damage modifiers in ovarian cancer.

Hui Li, PhD
Assistant Professor, Department of Pathology
Trans-splicing of mRNA as a novel method of generating chimeric oncogenes in endometrial cancers.

John C. Marshall, MD, PhD
Professor, Department of Medicine, Division of Endocrinology and Metabolism; Director, Center for Reproduction
Mechanisms regulating sex steroid synthesis, metabolic influences on steroid synthesis and polycystic ovarian disease; actions of activin/follistatin on cell growth and function.

Susan C. Modesitt, MD
Associate Professor, Department of Obstetrics and Gynecology and Chief, Division of Gynecological Oncology
Clinical and translational trials investigating the impact of obesity on the genesis and outcomes of endometrial cancer.

Christopher A. Moskaluk, MD, PhD
Associate Professor, Department of Pathology; Associate Director for Translational Infrastructure of the Cancer Center; (joint membership with Signaling Program)
Molecular analysis of primary human cancers by global genetic surveys and gene profiling; tissue arrays of breast tumors and normal breast tissues.

Sarah (Sally) J. Parsons, PhD
Professor, Department of Microbiology; Associate Director of Laboratory Research, Cancer Center
Actions of the Src proto-oncongene and HER family members in women’s cancers; pathways to therapeutic resistance in breast cancer.

Emilie F. Rissman, PhD
Professor, Department of Biochemistry and Molecular Genetics
Sex steroids, steroid receptors.

Richard J. Santen, MD
Professor, Department of Medicine, Endocrinology and Metabolism
Estrogen-regulated control of proliferation and differentiation of breast cancer cells; novel non-genomic actions of estrogen and interactions with IGF-1 and EGF receptor pathways.

Anneke T. Schroen, MD
Associate Professor, Department of Surgery; Breast Cancer Surgeon
Studies on patient accrual on cancer clinical trials and on patient and physician barriers to accrual with an emphasis on minority accrual.

Timothy N. Showalter, MD
Professor, Department of Radiation Oncology
Gynecologic cancers and radiation therapy.

Jill K. Slack-Davis, PhD
Assistant Professor, Department of Microbiology
Animal and cell models of ovarian and endometrial cancer; role of adhesion-dependent signaling pathways in regulating tumor progression and metastasis.

Michael O. Thorner, DSc, FACP, FRCP, MB
Professor, Department of Medicine, Division of Endocrinology and Metabolism
Growth hormone and growth factor actions in physiological and pathological states.

Mark B. Williams, PhD
Associate Professor, Department of Radiology
Unique imaging technologies for detection of breast cancer and assignment of breast cancer risk.

Associate Program Members

Kristen A. Atkins, MD
Associate Professor, Department of Pathology
Biomarkers for breast, ovarian, and uterine malignancies.

Christiana M. Brenin, MD
Assistant Professor, Department of Medicine, Division of Hematology/Oncology
Breast cancer clinical trials.

David Drake, MD
Associate Professor of Plastic Surgery
Effects of lipoaspirate on the damaging effects of radiation to breast patients

Jennifer A. Harvey, MD
Professor, Department of Radiology, Co-leader, Breast Cancer Interdisciplinary Clinical Care Team
Imaging trials relating mammographic breast density to genetic variation and breast cancer risk.

Mark Stoler, MD
Professor, Department of Pathology
Biomarkers and screening of gynecological malignancies.